Cardio Diagnostics Holdings, Inc. (CDIO)
1.65
-0.04
(-2.37%)
USD |
NASDAQ |
Nov 19, 16:00
1.63
-0.02
(-1.21%)
After-Hours: 20:00
Cardio Diagnostics Holdings Profit Margin (Quarterly) : -48.12K% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -48.12K% |
| June 30, 2026 | -27.81K% |
| March 31, 2026 | -66.23K% |
| December 31, 2025 | -40.71K% |
| September 30, 2025 | -59.12K% |
| June 30, 2025 | -22.44K% |
| March 31, 2025 | -181.7K% |
| Date | Value |
|---|---|
| December 31, 2024 | -33.76K% |
| September 30, 2024 | -21.40K% |
| June 30, 2024 | -16.30K% |
| March 31, 2024 | -26.19K% |
| December 31, 2023 | -26.21K% |
| September 30, 2023 | -19.32K% |
| June 30, 2023 | -236.6K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -10.95K% |
| Celularity, Inc. | 10.05% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -87.26% |
| Return on Assets | -69.17% |
| Return on Invested Capital | -82.12% |
| Gross Profit Margin (Quarterly) | -1.30K% |
| Operating Margin (Quarterly) | -48.06K% |
| Return on Net Operating Assets | -361.0% |